Activation of the transcription factor NF-κB in lipopolysaccharide-stimulated U937 cells

Biochemical Pharmacology

Volumn 53, Issue 3, 1997, Pages 339-346

  Legrand Poels, Sylvie ^a   Maniglia, Salvatore ^a   Boelaert, Johan R ^b   Piette, Jacques ^a,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b General Hospital St Jan   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

LPS; monocytes; NF B; oxidative stress; signal transduction

Indexed keywords

4 BROMOPHENACYL BROMIDE; ACETYLCYSTEINE; ANTIOXIDANT; CHLOROQUINE; CYTOKINE; FLUORESCENT DYE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOXYGENASE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR;

ARTICLE; BACTERIAL INFECTION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; KINETICS; LYSOSOME MEMBRANE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; BIOLOGICAL TRANSPORT; CELL LINE; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LIPOXYGENASE; MONOCYTES; NF-KAPPA B; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031041059     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00715-0     Document Type: Article

References (57)

1. Tracey KJ and Lowry SF, The role of cytokine mediators in spetic shock. Adv Surg 23: 21-67, 1990.
2. Sherry B and Cerami A, Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory response. J Cell Biol 107: 1269-1274, 1988.
3. Freudenberg MA, Keppler D and Galanos C, Requirement for lipopolysaccharide-sensitive macrophages in galactosamine-induced sensitization to endotoxin. J Clin Invest 79: 891-902, 1986.
4. Nathan CF, Secretory products of macrophages. J Clin Invest 79: 319-322, 1987.
5. Girardin e, Grau G, Drayer J, Roux-Lombart P, J5 Study Group and Lambert PH, Tumor necrosis factor and interleukin-1 in serum of children with severe infectious purpura. N Engl J Med 319: 397-402, 1988.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ and Mathison JC, CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1436, 1990.
7. Bright SW, Chen TY, Flebbe LM, Lei MG and Morrison DC, Generation and characterization of hamster-mouse hybridomas secreting monoclonal antibodies with specificity for lipopolysaccharide receptor. J Immunol 145: 1-11, 1990.
8. Geng Y, Zhang B and Lotz M, Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151: 6692-6700, 1993.
9. Liberman TA and Baltimore D, Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10: 2327-2338, 1990.
10. Shakhov AN, Collart MA, Vassali P, Nedospasov SA and Jongeneel CV, Kappa B type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171: 35-46, 1990.
11. Wiegmann K, Schütze S, Machleidt T, Witte D and Krönke M, Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015, 1994.
12. Mackman N, Brand K and Edgington TS, Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 174: 1517-1522, 1991.
13. Baeuerle PA and Henkel T, Function and activation of NF-κB in the immune system. Ann Rev Immunol 12: 141-179, 1994.
14. Siebenlist U, Franzoso G and Brown K, Structure, regulation,and function of NF-κB. Annu Rev Biol 10: 405-455, 1994.
15. Miyamoto S and Verma IM, Rel/NF-κB/IκB story. Adv Cancer Res 66: 255-292, 1995.
16. Beg AA and Baldwin AS, The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 7: 2064-2070, 1993.
17. Lux SE, John KM and Bennett V, Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344: 36-42, 1990.
18. Haskill S, Beg AA, Tompkins SM, Morris J, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P and Baldwin ASJ, Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65: 1281-1289, 1993.
19. Rice NR, MacKichan ML and Israél A, The precursor of NF-κB p50 has IκB-like functions. Cell 71: 243-253, 1992.
20. Mercurio F, DiDonato JA, Rosette C and Karin M, p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev 7: 705-718, 1993.
21. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P and Ghosh S, IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80: 573-582, 1995.
22. Beg AA, Finco TS, Nantermet PV and Baldwin ASJ, Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol Cell Biol 13: 3301-3310, 1993.
23. Brown K, Park S, Kanno T, Franzoso G and Siebenlist U, Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc Natl Acad Sci USA 90: 2532-2536, 1993.
24. Palombella VJ, Rando OJ, Goldberg AL and Maniatis T, The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785, 1994.
25. Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN, Wilk S and Baeuerle PA, Phosphorylation of IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14: 2876-2883, 1995.
26. Brown K, Gerstberger S, Carlson L, Franzoso G and Siebenlist U, Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1588, 1995.
27. Traenckner EB-M, Wilk S and Baeuerle PA, A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13: 5433-5441, 1994.
28. Schreck R, Rieber P and Baeuerle PA, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
29. Schultze-Osthoff K, Los M and Baeuerle P, Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol 50: 735-741, 1995.
30. Brennan P and O'Neill LAJ, Effect of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260: 167-175, 1995.
31. Betts JC, Agranoff AB, Nabel GJ and Shayman JA, Dissociation of endogenous cellular ceramide from NF-κB activation. J Biol Chem 269: 8455-8458, 1994.
32. Heller RA and Krönke M, Tumor necrosis factor-mediated signaling pathways. J Cell Biol 126: 5-9, 1994.
33. Johns LD, Sarr T and Ranges GE, Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-κB. J Immunol 152: 5877-5882, 1994.
34. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D and Pfizenmaier K, PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14: 1961-1969, 1995.
35. Legrand-Poels S, Bours V, Piret B, Pflaum M, Epe B, Rentier B and Piette J, Transcription factor NF-κB is activated by photosensitization generating oxidative DNA damages. J Biol Chem 270: 6925-6934, 1995.
36. 2 in cultured endothelial cells. Arch Biochem Biophys 302: 348-355, 1993.
37. Henkel T, Machleidt T, Alkalay I, Krönke M, Ben-Neriah Y and Baeuerle PA, Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365: 182-185, 1993.
38. Los M, Schenk H, Hexel K, Baeuerle PA, Dröge W and Schulze-Osthoff K, IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 14: 3731-40, 1995.
39. Lister MD, Glaser KB, Ulevitch RJ and Dennis EA, Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. J Biol Chem 264: 8520-8528, 1989.
40. Lozano J, Berra E, Municio MM, Diaz-Meco M, Dominguez I, Sanz L and Moscat J, Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem 269: 19200-19202, 1994.
41. Diaz-Meco MT, Berra E, Municio MM, Sanz L, Lozano J, Dominguez I, Diaz-Golpe V, Lain de Lera MT, Alcami J, Payà CV, Arenzana-Seisdedos F, Virelizier J-L and Moscat J, A dominant negative protein kinase C ζ subspecies blocks NF-κB activation, Mol Cell Biol 13: 4770-4775, 1993.
42. Mathias S, Younes A, Kan C-C, Orlow I, Joseph C and Kolesnick RN, Activation of Sphingomyelin signal pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259: 519-522, 1993.
43. Kolesnick R and Golde DW, The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328, 1994.
44. Machleidt T, Wiegmann K, Henkel T, Schütze S, Baeuerle PA and Krönke M, Sphingomyelinase activates proteolytic IκB-α degradation in a cell-free system. J Biol Chem 269: 13760-13765, 1994.
45. Reddy SAG, Chaturvedi MM, Darnay BG, Chan H, Higuchi M and Aggarwal BB, Reconstitution of nuclear factor κB activation induced by tumor necrosis factor requires membrane-associated components. J Biol Chem 269: 25369-25372, 1994.
46. Dbaibo GS, Obeid LM and Hannun YA, Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. J Biol Chem 268: 17762-17766, 1993.
47. Brach MA, de Vos S, Arnold C, Grub HJ, Mertelsmann R and Herrmann F, Leukotriene B4 transcriptionally activates interleukin-6 expression involving NF-κB and NF-IL6. Eur J Immunol 22: 2705-2711, 1992.
48. Feng L, Xia Y, Garcia GE, Hwang D and Wilson CB, Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 95: 1669-1675, 1995.
49. Cordle SR, Donald R, Read MA and Hawiger J, Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-rel and related NF-κB proteins in human monocytic THP-1. J Biol Chem 268: 11803-11810, 1993.
50. Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP and Bours V, Interleukin-1β induces nuclear factor κB in epithelial cells independently of the production of reactive oxygen intermediates. Eur J Biochem, in press.
51. Kang SM, Tran AC, Grilli M and Lenardo MJ, NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 256: 1452-1456, 1992.
52. Kunsch C, Ruben SM and Rosen CA, Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 12: 4412-4421, 1992.
53. Pruzanski W, Vadas P and Browning J, Phospholipase A2-A mediator between proximal and distal effectors of inflammation. Immunol Today 12: 143-146, 1991.
54. Pruzanski W, Vadas P and Browning J, Secretory non-pancreatic group II phospholipase A2 - role in physiologic and inflammatory processes. J Lipid Mediators 8: 161-167, 1993.
55. Aitdafoun M, Mounier C, Heymans F, Binisti C, Cassian B and Godfroid J-J, 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors. Biochem Pharmacol 51: 737-742, 1996.
56. Kazmi SMI, Plante RK, Visconti V, Taylor GR, Zhou L and Lau CY, Suppression of NF-κB activation and NF-κB-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem 57: 299-310, 1995.
57. Mitchell JA, Larkin S and Williams TJ, Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 50: 1535-1542, 1995.